User profiles for Xavier Mariette

Xavier Mariette

Université Paris-Saclay, Assistance Publique Hôpitaux de Paris, INSERM
Verified email at aphp.fr
Cited by 97151
[PDF] academia.edu

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS)

X Mariette, P Ravaud, S Steinfeld… - … : Official Journal of …, 2004 - Wiley Online Library
Objective. There is no effective treatment for patients with primary Sjögren’s syndrome (SS).
Since tumor necrosis factor (TNF) could be a key element in the pathogenesis of primary SS, …
Save Cite Cited by 551 Related articles All 11 versions
[PDF] whiterose.ac.uk

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, M Kouloumas, T Kvien, Z Li, X Mariette… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international Task …
Save Cite Cited by 3106 Related articles All 29 versions
[HTML] nih.gov

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

…, M Jung, G Kumánovics, X Mariette… - Arthritis & …, 2019 - Wiley Online Library
Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …
Save Cite Cited by 2719 Related articles All 34 versions
[HTML] jamanetwork.com

[HTML][HTML] Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial

O Hermine, X Mariette, PL Tharaux… - JAMA internal …, 2021 - jamanetwork.com
Importance Severe pneumonia with hyperinflammation and elevated interleukin-6 is a common
presentation of coronavirus disease 2019 (COVID-19). Objective To determine whether …
Save Cite Cited by 885 Related articles All 22 versions
[PDF] bmj.com

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

…, M Kouloumas, TK Kvien, X Mariette… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…
Save Cite Cited by 2880 Related articles All 18 versions
[PDF] bmj.com

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, TWJ Huizinga, M Koloumas, Z Li, X Mariette… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …
Save Cite Cited by 2622 Related articles All 22 versions
[HTML] nih.gov

Genetics of rheumatoid arthritis contributes to biology and drug discovery

…, HJ Guchelaar, TWJ Huizinga, P Dieudé, X Mariette… - Nature, 2014 - nature.com
A major challenge in human genetics is to devise a systematic strategy to integrate disease-associated
variants with diverse genomic and biological data sets to provide insight into …
Save Cite Cited by 2454 Related articles All 47 versions
[PDF] wiley.com

[PDF][PDF] 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data …

…, C Vitali, SJ Bowman, X Mariette… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop and validate an international set of classification criteria for primary
Sjögren's syndrome (SS) using guidelines from the American College of Rheumatology (ACR) …
Save Cite Cited by 2365 Related articles All 30 versions
[HTML] nih.gov

Immune-related adverse events of checkpoint inhibitors

…, MA Khamashta, O Lambotte, X Mariette… - Nature reviews Disease …, 2020 - nature.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
Save Cite Cited by 881 Related articles All 10 versions
[HTML] nejm.org

[HTML][HTML] Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

…, F Lefrère, JP Bronowicki, X Mariette… - … England Journal of …, 2002 - Mass Medical Soc
Background Some epidemiologic studies suggest a link between hepatitis C virus (HCV)
infection and some B-cell non-Hodgkin's lymphomas. We undertook this study after a patient …
Save Cite Cited by 983 Related articles All 9 versions